{"id":21733,"date":"2022-05-04T16:49:17","date_gmt":"2022-05-04T16:49:17","guid":{"rendered":"https:\/\/www.hri-research.org\/?p=21733"},"modified":"2022-07-15T15:47:58","modified_gmt":"2022-07-15T15:47:58","slug":"randomised-controlled-trials-data-update-2021","status":"publish","type":"post","link":"https:\/\/www.hri-research.org\/bg\/2022\/05\/randomised-controlled-trials-data-update-2021\/","title":{"rendered":"Randomised controlled trials data update 2021"},"content":{"rendered":"

We are pleased to announce the <\/span>findings from Dr Robert Mathie\u2019s <\/span>latest clinical evidence update:<\/span><\/p>\n

Total number of randomised controlled trials (RCTs):<\/b><\/span>
\n2021:\u00a0<\/b>255 RCTs of homeopathic treatments for 136 medical conditions<\/p>\n

It is promising to see a slight increase in the volume of trials published per year, i.e. 14 RCTs in 2021, compared to 12 RCTs in 2020.<\/span><\/p>\n

Double-blind placebo-controlled trials (DB-RCTs):
\n<\/b><\/span>Considering only DB-RCTs in humans, published in peer reviewed journals (excluding prophylaxis and cross-over studies), the analysis found<\/span>:<\/span><\/p>\n

2020<\/b>:\u00a0140 trials\u00a0on 86 different medical conditions<\/span>
\n<\/span>2021<\/b>:\u00a0<\/span>148 trials<\/span><\/a>\u00a0on 88 different medical conditions<\/span><\/p>\n

 <\/p>\n

148 RCTs of homeopathy (end of 2021)\u2029<\/strong><\/p>\n

\"\"<\/p>\n

The 8 new DB-RCTs – 2 positive<\/strong>1,2<\/sup> 0 negative and 6 inconclusive<\/strong><\/span>3-8<\/sup>\u00a0trials<\/strong> – have resulted in a slight shift in the overall balance of evidence as follows:<\/p>\n

Positive: \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/span>\u2193 1%<\/span>
\n<\/span>Negative:\u00a0<\/span>\u00a0 \u00a0 \u00a0 \u2193\u00a02%<\/span>
\n<\/span>Inconclusive<\/span>: \u2191\u00a02%<\/span><\/p>\n

Our most popular\u00a0<\/span>FAQ webpage<\/span><\/a>\u00a0has been updated to include:<\/span><\/p>\n